Uso de una composicion farmaceutica que comprende un derivado de 4-pregenen-11beta-17-21-triol-3,20-diona para tratar una condicion ocular tal como presion intraocular elevada, glaucoma, uveitis, degeneracion macular, retinopatia diabetica, rosacea ocular, desprendimiento de retina, entre otras.
The present invention relates to novel 4-pregenen-11β-17-21-triol-3,20-dione derivatives, processes for preparing them, pharmaceutical compositions containing them and their use as pharmaceuticals, as modulators of glucocorticoid or mineralocorticoid receptors. The invention relates specifically to the use of these compounds and their pharmaceutical compositions to treat disorders associated with glucocorticoid or mineralocorticoid receptor modulation.USO DE UNA COMPOSICION FARMACEUTICA QUE COMPRENDE UN DERIVADO DE 4-PREGENEN-11BETA-17-21-TRIOL-3,20-DIONA PARA TRATAR UNA CONDICION OCULAR TAL COMO PRESION INTRAOCULAR ELEVADA, GLAUCOMA, UVEITIS, DEGENERACION MACULAR, RETINOPATIA DIABETICA, ROSACEA OCULAR, DESPRENDIMIENTO DE RETINA, ENTRE OTRAS.